New GLP-1 pill delivers up to 12% weight loss in 36 weeks
A new oral approach to GLP-1 treatment helped adults with obesity or overweight lose as much as 12 percent of their body weight over 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine. Robert Kushner, MD, ’82 GME, professor emeritus of Medicine in the Division…
